| |
|||||
| in | |||||
| WEB | |||||
|
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high ...
Pancreatic ductal adenocarcinoma (PDAC) arises from precursor lesions over a decade-plus, offering a window for interception in high-risk ...
|
|||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
|
Send Feedback
|
No comments:
Post a Comment